US equities |
SPCX $166.99 ▲+5.05% NVDA $237.22 ▲+1.40% MU $1,065.18 ▼-0.90% TSLA $377.67 ▲+1.91% MSFT $525.31 ▲+1.50% INTC $116.50 ▼-2.38% SNDK $1,712.80 ▼-0.42% META $745.61 ▲+2.41%
FinancialContent

Instil Bio, Inc. (NQ:TIL)

7.220 UNCHANGED
Delayed Quote Updated: 10:29 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Instil Bio, Inc.

< Previous 1 2 3 4 5 6 Next >
News headline image
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting
Presented novel preclinical data showing that CoStAR enhances activity of CD4+ T cells in multiple ways to broaden anti-tumor response and support CD8+ T cells 
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio Resumes ITIL-306 Study In Lung, Ovarian, Renal Cancers ↗
 
Via Benzinga
What 4 Analyst Ratings Have To Say About Instil Bio ↗
 
Via Benzinga
News headline image
Instil Bio Discontinues ITIL-168 Cancer Trials, Layoffs 60% Of Its Employees ↗
 
Via Benzinga
News headline image
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Instil Bio
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023 ↗
 
Via Benzinga
News headline image
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Instil Bio
Via GlobeNewswire
News headline image
NASDAQ:TIL Shareholder Notice: Investigation over Potential Wrongdoing at Instil Bio, Inc. ↗
San Diego, CA -- (SBWIRE) -- 02/10/2023 -- Certain directors of Instil Bio, Inc. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
News headline image
Instil Bio Announces Extension of Cash Runway Beyond 2026 with the Consolidation of R&D Operations to its Manchester, U.K. Site
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer
From Instil Bio
Via GlobeNewswire
News headline image
INSTIL BIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Instil Bio, Inc. on Behalf of Instil Bio Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 241 companies hit new 52-week lows. 
Via Benzinga
News headline image
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal... 
Via Benzinga
News headline image
Bragar Eagel & Squire, P.C. Is Investigating PROG, Fox, Instil, and Twist and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  OnFriday, 143 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 115 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Newman Ferrara LLP Announces Corporate Governance Investigations of Instil Bio, Inc. (TIL)
From Newman Ferrara LLP
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  Monday saw 196 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 127 companies set new 52-week lows. 
Via Benzinga
News headline image
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's trading, 138 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Instil Bio Announces Prioritization of Genetically Engineered CoStAR-TIL Program with ITIL-306 in Advanced Solid Tumors and Reduction in Workforce
From Instil Bio
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday's session saw 167 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >